DRUGS THAT INDUCE SYSTEMIC LUPUS ERYTHEMATOSUS INHIBIT COMPLEMENT COMPONENT C4
- 1 January 1984
- journal article
- research article
- Published by Elsevier
- Vol. 324 (8400) , 422-424
- https://doi.org/10.1016/s0140-6736(84)92905-2
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Local opsonization by secreted macrophage complement components. Role of receptors for complement in uptake of zymosan.The Journal of Experimental Medicine, 1984
- A standardized method for quantitating the complement-mediated immune complex solubilizing capacity of human serumJournal of Immunological Methods, 1983
- The chemical induction of systemic lupus erythematosus and lupus‐like illnessesArthritis & Rheumatism, 1981
- Covalent binding and hemolytic activity of complement proteins.Proceedings of the National Academy of Sciences, 1980
- The binding of human complement component C4 to antibody-antigen aggregatesBiochemical Journal, 1980
- Studies on the mechanism of solubilization of immune precipitates by serum.The Journal of Experimental Medicine, 1976
- Antinuclear antibodies during procainamide treatment and drug acetylation.BMJ, 1975
- DRUGS AND ???DISSEMINATED LUPUS ERYTHEMATOSUS???Adverse Drug Reaction Bulletin, 1973
- GENETIC VARIATIONS IN THE ACETYLATION OF ISONIAZID AND OTHER DRUGSAnnals of the New York Academy of Sciences, 1968
- THE LOCALIZATION OF CIRCULATING IMMUNE COMPLEXES IN EXPERIMENTAL SERUM SICKNESSThe Journal of Experimental Medicine, 1968